Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...
EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...
EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The ...
Diabetes Mellitus has become a worldwide epidemic, affecting approximately 425 million people. Unfortunately, one in two patients remains undiagnosed. HbA1c can play a major role in finding these ...
EKF Diagnostics has announced that in a newly published paper [1] its Quo-Test® point-of-care (POC) hemoglobin A1c (HbA1c) analyzer has again been confirmed to meet International Federation of ...
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October) and published in the journal Diabetes Therapy suggests that ...
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Hemoglobin A1C (HbA1C) Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
DUBLIN, IRELAND--(Marketwired - Aug 8, 2014) - Research and Markets (http://www.researchandmarkets.com/research/vfzzkh/hemoglobin_a1c) has announced the addition of ...
While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia is among the first to show the subsequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback